Table 6.

Antibiotic treatments after the antibiogram was available.

Antibiotics	With underlying diseases (%)	Without underlying diseases (%)	Clinical cure (%)
Meropenem (n = 15)	9 (60)	6 (40)	10 (66.67)
Piperacillin-tazobactam (n = 6)	4 (66.67)	2 (33.33)	5 (83.33)
Cefepime (n = 5)	3 (60)	2 (40)	3 (60)
TMP-SMX (n = 4)	3 (75)	1 (25)	4 (100)
cefoperazone-sulbactam (n = 4)	1 (25)	3 (75)	4 (100)
ceftazidime (n = 3)	2 (66.67)	1 (33.33)	2 (66.67)
ceftriaxone (n = 2)	2 (100)	0	1 (50)
levofloxacin (n = 1)	1 (100)	0	1 (100)
Imipenem and Cilastatin Sodium (n = 1)	0	1 (100)	1 (100)
Mezlocillin-sulbactam (n = 1)	0	1 (100)	1 (100)
cefmetazole (n = 1)	0	1 (100)	1 (100)
Piperacillin-tazobactam combination with levofloxacin (n = 1)	1 (100)	0	1 (100)
Meropenem combination with Tigecycline (n = 1)	0	1 (100)	1 (100)
Meropenem combination with ceftazidime (n = 3)	1	2 (66.67)	2 (66.67)
Meropenem combination with TMP-SMX (n = 1)	1 (100)	0	0
Cefoperazone-sulbactam combination with TMP-SMX (n = 1)	0	1 (100)	1 (100)